Results 191 to 200 of about 11,651 (307)

In‐situ asphaltene capture with iron oxide nanoparticles in steam‐assisted gravity drainage (SAGD) for improved recovery and partial upgrading of bitumen

open access: yesThe Canadian Journal of Chemical Engineering, EarlyView.
Key improvements obtained by incorporating nanoparticles into a lab‐scale SAGD process configuration. The bar plots show enhanced oil recovery, reduced viscosity, and increased asphaltene adsorption in nanoparticle‐assisted scenarios compared with conventional SAGD.
Luis Prada   +6 more
wiley   +1 more source

Swearing as a catalyst of technological development. [PDF]

open access: yesFront Psychol
Benítez-Burraco A, Washmuth N.
europepmc   +1 more source

Bemnifosbuvir: An HCV NS5B Inhibitor With Multiple Modes of Action

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Bemnifosbuvir (BEM) is a potent, pan‐genotypic inhibitor targeting the hepatitis C virus (HCV) NS5B polymerase. Its antiviral activity was evaluated in an ascending dose phase I clinical trial involving 30 patients treated once a day for 7 days. After treatment initiation, plasma HCV RNA declined in a biphasic manner with a mean reduction of 2.3 log10 ...
Carolin Zitzmann   +4 more
wiley   +1 more source

Maintaining cultural identity in design: shape grammar as means of identifying and modifying design style.

open access: yes
This research is an attempt to find an objective system for maintaining cultural identity in design. The proposed framework will guide interior designers to identify the key features and design language of their traditional style, and then to modify it ...
Alsallal, Abdulaziz S.
core  

Ruxolitinib Pharmacokinetics and Exposure–Toxicity Relationship in Hematologic Malignancies and Immune‐Mediated Diseases: A Prospective Observational Study

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Ruxolitinib pharmacokinetics (PK) has been characterized in clinical trials but remains poorly documented in real‐world practice. This project aimed to investigate ruxolitinib PK in routine clinical practice, identify factors driving its variability, and explore exposure–response relationships to assess the potential role of therapeutic drug monitoring.
Jérémie Tachet   +11 more
wiley   +1 more source

Beyond Symbolism: Examining the Impact of Sustainable Finance on Product Responsibility and the Moderating Role of Board Environmental Expertise—Evidence From UK Non‐Financial Firms

open access: yesCorporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT Despite the growing emphasis on sustainable finance in today's corporate landscape, its impact on product responsibility remains underexplored, particularly the moderating role of board environmental expertise. This study addresses these gaps by examining non‐financial companies listed on the London Stock Exchange, chosen for the UK's ...
Bright Akwasi Gyamfi   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy